Distributed Biomanufacturing Facilities of the Future
Biotechnology and Bioengineering · 2025-11 · 122 (11) · 3249-3265
DOI: 10.1002/bit.70039 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2025-08-07. Written by Revati Kadolkar and 17 co-authors. Institution: Department of Chemical, Biochemical and Environmental Engineering, Center for Advanced Sensor Technology, University of Maryland Baltimore County, Ba…. Major MEDLINE topics: Biological Products, Biotechnology. Cited 9 times so far (Crossref); 99 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
The future of healthcare depends on leveraging state‐of‐the‐art advancements in biopharmaceutical manufacturing across the world. A near end‐to‐end distributed biomanufacturing setup will enable production to occur closer to points‐of‐care or points‐of‐need, thereby reducing lead times, improving adaptability to unseasonal demands and ensuring accessibility in rural and resource‐limited settings. However, the current distributed biomanufacturing systems typically produce lower volumes compared to conventional facilities. This perspective discusses the present status of distributed biomanufacturing and envisions futuristic models on portable platforms providing high mobility and production capacity. This conceptual framework for deployable biomanufacturing could facilitate an impartial global distribution of biotherapeutics, improved pandemic preparedness, reduced production costs, provide medical tourism and even utilization in space exploration. By integrating advanced technologies such as continuous manufacturing, machine learning, sensors, and real‐time process control, these platforms would enable rapid, agile, and efficient production of biologics. Furthermore, we discuss key considerations such as regulatory pathways, quality management systems and secure cloud‐based data handling for one such mobile platform housed on a ship. This vision for distributed biomanufacturing aims to spark innovation and drive efforts toward the futuristic goal of providing affordable and high‐quality biopharmaceuticals with equitable access around the world.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical, Biochemical and Environmental Engineering, Center for Advanced Sensor Technology, University of Maryland Baltimore County, Baltimore, Maryland, USA.
- Department of Chemical, Biochemical and Environmental Engineering, University of Maryland Baltimore County, Baltimore, Maryland, USA.
- University of Maryland Baltimore County, Shady Grove, Maryland, USA.
- Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, Maryland, USA.
ORCID profiles: Chad Sundberg, Xudong Ge, Venkatesh Srinivasan, Govind Rao
Funding
- The authors received no specific funding for this work.
Cite
APA
Kadolkar, R., Kumar, V., Thole, A., Patel, D., Ujjain, S. K., George, I., Wei, Y., Prajapati, T., Zafar, S., Faris, N., Rezaei, P., Tolosa, M., Sundberg, C., Ge, X., Frey, D. D., Moreira, A., Srinivasan, V., & Rao, G. (2025). Distributed Biomanufacturing Facilities of the Future. Biotechnology and Bioengineering, 122(11), 3249-3265. https://doi.org/10.1002/bit.70039
Vancouver
Kadolkar R, Kumar V, Thole A, Patel D, Ujjain SK, George I, et al. Distributed Biomanufacturing Facilities of the Future. Biotechnology and Bioengineering. 2025;122(11):3249-3265. doi:10.1002/bit.70039
BibTeX
@article{Kadolkar2025,
author = {Kadolkar, Revati and Kumar, Vikash and Thole, Aaron and Patel, Diya and Ujjain, Sanjeev Kumar and George, Iyowunari and Wei, Yunqian and Prajapati, Tithi and Zafar, Sania and Faris, Neveen and Rezaei, Pegah and Tolosa, Michael and Sundberg, Chad and Ge, Xudong and Frey, Douglas D and Moreira, Antonio and Srinivasan, Venkatesh and Rao, Govind},
title = {Distributed Biomanufacturing Facilities of the Future},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {11},
pages = {3249--3265},
doi = {10.1002/bit.70039}
}
EUVIMED